LONDON - UK biotechnology reached the end of an era last week with the announcement that British Biotech plc will take over Vernalis plc in an agreed-to £48 million (US$79.7 million) deal, ditching the British Biotech moniker and closing the company's facility in Oxford. (BioWorld International)

LONDON - UK biotechnology reached the end of an era last week with the announcement that British Biotech plc will take over Vernalis plc in an agreed-to £48 million (US$79.7 million) deal, ditching the British Biotech moniker and closing the company's facility in Oxford. (BioWorld International)

LONDON - Consolidation of UK biotechnology continues apace with the announcement that British Biotech plc will take over Vernalis plc in a £48 million (US$79.7 million) all-share deal that comes just three months after British Biotech's takeover of RiboTargets Holdings plc. (BioWorld Today)

LONDON - Consolidation of UK biotechnology continues apace with the announcement that British Biotech plc will take over Vernalis plc in a £48 million (US$79.7 million) all-share deal that comes just three months after British Biotech's takeover of RiboTargets Holdings plc. (BioWorld Today)